TG Therapeutics reported 10.76 in PE Price to Earnings for its fiscal quarter ending in December of 2025.





Pe Change Date
AbbVie 23.03 1 Mar/2026
Amgen 19.84 5.47 Mar/2026
Bayer 3.4 8.75 Mar/2026
Biogen 13.7 0.32 Mar/2026
Corcept Therapeutics 113.58 71.67 Mar/2026
Gilead Sciences 17.7 2.07 Mar/2026
J&J 24.53 0.91 Mar/2026
Novartis 20.17 2.32 Mar/2026
Novavax 2.01 1.07 Dec/2025
PTC Therapeutics 9.98 3.25 Dec/2025
Puma Biotechnology 13.93 44.88 Jun/2024
Regeneron Pharmaceuticals 25.14 7.03 Mar/2026
Roche Holding 16.09 3.51 Dec/2025
TG Therapeutics 10.76 2.32 Dec/2025
Vertex Pharmaceuticals 25.82 0.33 Mar/2026